Conclusion
we believe the incidence of this opportunistic infection is increasing
due to the higher incidence of the mentioned risk factors and the key
solution was early detection since mucormycosis has broad manifestation
and correct intervention to reduce mortality and morbidity.
Author contributions: GS, NAD, and MAS were involved in the
interpretation and collecting of data and editing of the manuscript,
MADO was involved in drafting the first version of the manuscript and
editing, and GB was involved in collecting data and editing and
submitting the manuscript. All authors reviewed the paper and approved
the final version of the manuscript.
References:
1. Bhattacharyya, A., et al., Rhino-orbital-cerebral-mucormycosis
in COVID-19: A systematic review. Indian journal of pharmacology, 2021.53 (4): p. 317-327.
2. Petrikkos, G., et al., Epidemiology and clinical manifestations
of mucormycosis. Clin Infect Dis, 2012. 54 Suppl 1 : p. S23-34.
3. White, P.L., et al., A National Strategy to Diagnose
Coronavirus Disease 2019-Associated Invasive Fungal Disease in the
Intensive Care Unit. Clin Infect Dis, 2021. 73 (7): p.
e1634-e1644.
4. SeyedAlinaghi, S., et al., The clinical outcomes of COVID-19 in
HIV-positive patients: A systematic review of current evidence.Immunity, Inflammation and Disease, 2021. 9 (4): p. 1160-1185.
5. Uraguchi, K., et al., A case of rhinocerebral mucormycosis with
brain abscess drained by endoscopic endonasal skull base surgery.Medical Mycology Case Reports, 2020. 30 : p. 22-25.
6. Therakathu, J., et al., Imaging features of rhinocerebral
mucormycosis: A study of 43 patients. The Egyptian Journal of Radiology
and Nuclear Medicine, 2018. 49 (2): p. 447-452.
7. Sharma, S., et al., Post coronavirus disease mucormycosis: a
deadly addition to the pandemic spectrum. J Laryngol Otol, 2021.135 (5): p. 442-447.
8. Roushdy, T. and E. Hamid, A case series of post COVID-19
mucormycosis—a neurological prospective. The Egyptian Journal of
Neurology, Psychiatry and Neurosurgery, 2021. 57 (1): p. 100.
9. Hirabayashi, K.E., et al., Retrobulbar Injection of
Amphotericin B for Orbital Mucormycosis. Ophthalmic Plast Reconstr
Surg, 2017. 33 (4): p. e94-e97.